[Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].
Moragues
María Dolores
MD
Departamento de Enfermería I, EUE, Universidad del País Vasco, Vizcaya, Spain. nfpmotom@lg.ehu.es
Amutio
Elena
E
García-Ruiz
Juan Carlos
JC
Pontón
José
J
D000935:Antifungal Agents / Q000627:therapeutic use; D000946:Antigens, Fungal / Q000097:blood*; D001228:Aspergillosis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D001230:Aspergillus / Q000276:immunology / Q000302:isolation & purification; D015415:Biomarkers; D004797:Enzyme-Linked Immunosorbent Assay; D005500:Follow-Up Studies; D016469:Fungemia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D005690:Galactose / Q000031:analogs & derivatives; D006801:Humans; D016867:Immunocompromised Host; D008351:Mannans / Q000097:blood*; D009503:Neutropenia / Q000150:complications; D010357:Patient Isolators; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012306:Risk; D012680:Sensitivity and Specificity; D013997:Time Factors
D000935:Antifungal Agents; D000946:Antigens, Fungal; D015415:Biomarkers; D008351:Mannans; C012990:galactomannan; D005690:Galactose
Utilidad de la detección de galactomanano en el diagnóstico y seguimiento de la aspergilosis invasora en pacientes hematológicos.